Skip to main content
Premium Trial:

Request an Annual Quote

Biacore Reports Strong Q2 Sales Growth as '05 Tax Credit Impacts Earnings

NEW YORK (GenomeWeb News) - Biacore today said that despite a 21-percent jump in sales for the second quarter, profits dropped 80 percent as as a tax credit inaffected Q2 2005 earnings, and costs in the current period increased.
 
For the quarter ended June 30, sales rose 21 percent to SEK 162 million ($22.1 million) from SEK 133 million a year ago. Sales in Europe and US rose 33 percent and 48 percent, respectively, but Asia-Pacific sales declined by 50 percent.
 
Biacore, which is set to be acquired by GE Healthcare, posted second-quarter net income of SEK 23 million, or SEK 2.38 per share, versus SEK 113 million, or SEK 11.62 per share, during the same period last year. The company said contributing to the decline in profits this quarter was a SEK 97 million tax credit included in net income for the second quarter 2005.
 
R&D spending declined to SEK 26 million from SEK 27 million in the second quarter of 2005.
 
The company modified its forecast for the full-year 2006. Biacore said it expects 2006 sales to increase "at a somewhat higher rate than in 2005 with operating income growing faster than sales."
 
As of June 30, Bioacore had SEK 181.6 million in cash and cash equivalents.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.